2021
DOI: 10.1016/j.ijbiomac.2021.09.112
|View full text |Cite
|
Sign up to set email alerts
|

A review on albumin as a biomaterial for ocular drug delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
25
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(25 citation statements)
references
References 103 publications
0
25
0
Order By: Relevance
“…A globular heart-shaped “Bovine serum albumin (BSA)” is a simple and cost-effective protein with appealing properties, including biodegradation and biocompatibility, which has been extensively reported for drug delivery and extended for therapeutic and medicinal uses, including ocular distribution [ 1 , 2 , 3 , 4 , 5 ]. It is one component of the tissue-culture media, and a scaffold based on albumin should work well for cell and tissue engineering because it can provide structural support [ 6 , 7 , 8 ].…”
Section: Introductionmentioning
confidence: 99%
“…A globular heart-shaped “Bovine serum albumin (BSA)” is a simple and cost-effective protein with appealing properties, including biodegradation and biocompatibility, which has been extensively reported for drug delivery and extended for therapeutic and medicinal uses, including ocular distribution [ 1 , 2 , 3 , 4 , 5 ]. It is one component of the tissue-culture media, and a scaffold based on albumin should work well for cell and tissue engineering because it can provide structural support [ 6 , 7 , 8 ].…”
Section: Introductionmentioning
confidence: 99%
“…In addition, in vivo comparison of the biodistribution in posterior ocular tissues in rabbits revealed increased retention in the retina due to encapsulation in the nanosystem rather than with a solution of model drug [ 135 , 136 ]. Albumin is widely used in the preparation of ocular nanosystems [ 137 ]. In a recent study, bovine serum albumin nanoparticles loaded with apatinib were prepared for the treatment of diabetic retinopathy.…”
Section: Fluorescent Nanosystems In Ocular Applicationmentioning
confidence: 99%
“…Moreover, rapid clearance remains a challenge for nanosystems as they need to release their payload before being eliminated from the eye. Many studies focus on assessing the distribution in various tissues once the formulation has been instilled into the eye [ 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 , 125 , 126 , 127 , 128 , 129 , 130 , 131 , 132 , 134 , 137 , 138 , 139 ]. Unfortunately, few studies focus on assessing how mechanisms including blinking, tear drainage and ocular metabolism may interact with nanosystems [ 66 , 115 ].…”
Section: Challenges and Future Perspectivesmentioning
confidence: 99%
“…Polymer nanoparticles are also useful for delivering drugs to hard-to-reach tissues and organs. For instance, they can facilitate drug permeation to challenging anatomic structures, such as the inner ear [241][242][243][244], retina [245][246][247][248][249], brain [250][251][252][253][254], and avascular connective tissues [255][256][257].…”
Section: Drug Deliverymentioning
confidence: 99%